wayground logo

Free Printable Worksheets

NEW

Font size

S
M
L
XL
Worksheets

miastenia gravis - biofisica AL

Total questions: 41

Worksheet time: 21mins

Name
Class
Date
1.

Sobre os sintomas oculares: O início dos problemas nos olhos foi:

a)

De repente

b)

Gradualmente

2.

Sobre os sintomas oculares: O peso nos olhos piora ao longo do dia e melhora com o repouso?

a)

Sim

b)

Não

3.

Sobre os sintomas oculares: Como você descreveria a dificuldade em fechar as pálpebras?

a)

Constante

b)

Intermitente

c)

Não apresenta dificuldade

4.

A exoftalmia surgiu de repente ou progressivamente?

a)

De repente

b)

Progressivamente

5.

A visão turva ocorre:

a)

Constantemente

b)

Em momentos específicos

c)

Em ambos os olhos

d)

Apenas em um olho

6.

O desconforto cervical anterior começou há quanto tempo?

a)

Há poucos dias

b)

Há semanas

c)

Há meses

d)

Não sei

7.

Sobre o desconforto cervical anterior: Você apresenta dificuldade para engolir associada a esse desconforto?

a)

Sim

b)

Não

8.

O desconforto na face e garganta é mais frequentemente descrito como:

a)

Dor

b)

Formigamento

c)

Pressão

d)

Outro

9.

A voz nasalada que você percebeu é:

a)

Constante

b)

Intermitente

c)

Não percebi voz nasalada

d)

Não sei

10.

Sobre a dificuldade em sorrir e parestesias faciais: Quando você notou a dificuldade em sorrir? Sente alguma fraqueza nos músculos da face?

a)

Sim, sinto fraqueza nos músculos da face.

b)

Não, não sinto fraqueza nos músculos da face.

c)

Notei a dificuldade recentemente.

d)

Não notei nenhuma dificuldade.

11.

Sobre a dificuldade em sorrir e parestesias faciais: Em qual região do rosto você sente as parestesias ao sorrir?

a)

Testa

b)

Bochechas

c)

Lábios

d)

Queixo

12.

A dificuldade em engolir começou há:

a)

Menos de uma semana

b)

1-4 semanas

c)

Mais de um mês

d)

Não sei

13.

Você tem sentido fadiga ou fraqueza em outras partes do corpo?

a)

Sim

b)

Não

14.

Você tem alguma história de doenças autoimunes na família ou pessoal?

a)

Sim

b)

Não

15.

Você tem alguma outra condição médica conhecida?

a)

Sim

b)

Não

16.

Selecione o tipo de medicamento que você está tomando atualmente:

a)

Antibióticos

b)

Analgésicos

c)

Antidepressivos

d)

Não estou tomando nenhum medicamento

17.

Houve alguma mudança recente na sua saúde geral ou algum evento marcante antes do início desses sintomas?

a)

Sim

b)

Não

18.

Which of the following is a classic symptom of Myasthenia Gravis (MG)?

a)

Weight loss

b)

Difficulty in completely closing the eyelids due to muscle weakness

c)

High fever

d)

Joint pain

19.

What does 'ptose palpebral' (drooping of the eyelid) suggest in the context of Myasthenia Gravis?

a)

It is highly suggestive of MG.

b)

It rules out MG.

c)

It is a sign of diabetes.

d)

It is unrelated to neurological disorders.

20.

Facial paresthesia and difficulty smiling are due to weakness of which muscles in Myasthenia Gravis?

a)

Facial muscles

b)

Extraocular muscles

c)

Deltoid muscles

d)

Gastrocnemius muscles

21.

Which symptom is less common in Myasthenia Gravis and points to other conditions such as Graves' Disease?

a)

Ptosis

b)

Exophthalmos

c)

Dysphagia

d)

Nasal voice

22.

Bulbar muscle involvement causing dysphagia is common in Myasthenia Gravis.

a)

True

b)

False

23.

What is a possible visual symptom secondary to weakness of ocular muscles in Myasthenia Gravis?

a)

Blurred vision or diplopia (double vision)

b)

Sudden loss of consciousness

c)

Hearing loss

d)

Nasal congestion

24.

The absence of significant changes in thyroid function tests would make which diagnosis less likely, despite the presence of exophthalmos?

a)

Myasthenia Gravis

b)

Graves' Disease

c)

Multiple Sclerosis

d)

Parkinson's Disease

25.

What percentage of Myasthenia Gravis patients have anti-acetylcholine receptor antibodies?

a)

86%

b)

50%

c)

30%

d)

100%

26.

In Myasthenia Gravis, what is the role of the thymus gland?

a)

70% of patients have thymic enlargement (thymoma), and 10-15% have thymoma.

b)

It produces antibodies against acetylcholine directly.

c)

It is always atrophied in all patients.

d)

It has no involvement in the disease process.

27.

In normal neuromuscular junctions, acetylcholine is released from the presynaptic membrane and leads to muscle contraction.

a)

True

b)

False

28.

Which of the following is NOT a typical finding in the neuromuscular junction of Myasthenia Gravis patients?

a)

A) Reduction in the number of acetylcholine receptors

b)

B) Increase in the size of the neuromuscular junction

c)

C) Destruction of nerve terminals in the motor plate

d)

D) Increase in acetylcholine production

29.

What percentage of Myasthenia Gravis patients have anti-MuSK antibodies?

a)

About 10%

b)

About 1%

c)

About 50%

d)

About 30%

30.

Fill in the blank: Grupo I (25%) – Miastenia ocular is characterized by fatigue and weakness in the external ocular muscles, affecting one or both eyes. The prognosis is ________, and muscle weakness does not spread to other muscle groups in the first two years.

a)

excellent

b)

poor

c)

uncertain

d)

fatal

31.

Fill in the blank: Grupo IIA (35%) – Miastenia generalizada leve involves generalized, mild, and progressive MG, with involvement of cranial muscles, lower limbs, and trunk, sparing respiratory muscles. The prognosis is ________.

a)

good

b)

poor

c)

uncertain

d)

fatal

32.

Fill in the blank: Grupo IIB (20%) – Miastenia generalizada moderada is characterized by generalized and moderately intense and progressive MG. The prognosis is relatively ________, with a less satisfactory therapeutic response than in Group IIA.

a)

good

b)

poor

c)

uncertain

d)

excellent

33.

Fill in the blank: Grupo III (11%) – Miastenia aguda fulminante is characterized by rapid and progressive disease evolution, less than three months, leading to rapid and early atrophy of all ocular, skeletal, and bulbar muscles, including respiratory muscles. The prognosis is ________.

a)

poor

b)

excellent

c)

uncertain

d)

favorable

34.

Fill in the blank: Grupo IV (9%) – Miastenia generalizada severa tardia is characterized by severe generalized MG that becomes generalized in the first or second year after onset. The prognosis is ________.

a)

poor

b)

excellent

c)

uncertain

d)

benign

35.

According to the classification by Osserman and Genkins, which group of MG has the highest percentage of thymomas?

a)

Grupo I

b)

Grupo II

c)

Grupo III

d)

Grupo IV

36.

Fill in the blank: Tipo I MG is characterized by the ________ of thymoma, with no relation to sex, and MG is usually intense.

a)

presence

b)

absence

c)

recurrence

d)

treatment

37.

Fill in the blank: Tipo II MG is characterized by the ________ of thymoma and occurs predominantly in women before age 40.

a)

absence

b)

presence

c)

enlargement

d)

reduction

38.

Fill in the blank: Tipo III MG is characterized by the absence of thymoma and occurs predominantly in ________ after age 40.

a)

men

b)

children

c)

adolescents

d)

women

39.

Fill in the blank: Miastenia Gravis Juvenil is defined by the onset of signs and symptoms between the ________ and ________ year of age.

a)

1st; 18th

b)

2nd; 12th

c)

5th; 21st

d)

10th; 16th

40.

Miastenia Gravis Autoimune Neonatal Transitória can occur in up to ________% of neonates born to mothers with MG.

a)

10

b)

1

c)

25

d)

50

41.

Fill in the blank: Miastenia Familiar is associated with a genetic predisposition, and up to ________% of patients have a maternal relative with MG or other autoimmune diseases.

a)

30

b)

5

c)

50

d)

70